ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ: ОТ ABEL AYERZA ДО НАШИХ ДНЕЙ (ОБЗОР ЛИТЕРАТУРЫ)
Аннотация
В приведенном обзоре представлены краткая историческая справка и современное состояние проблемы легочной гипертензии – группы тяжелых состояний, характеризующихся обструктивной перестройкой сосудистого русла легких, приводящей к прогрессирующей правожелудочковой недостаточности. Отмечено, что, несмотря на прогресс, достигнутый в понимании механизмов развития, диагностике и лечении, некоторые формы болезни остаются на текущий момент неизлечимыми, что является стимулом для специалистов разных областей для разработки и применения новых методов диагностики и лечения.
Литература
1. Mazzei J.A., Mazzei M.E. A tribute: Abel Ayerza and pulmonary hypertension. Eur. Respir. Rev. 2011; 20 (122): 220-221. doi:10.1183/09059180.00006811
2. Heath Donald, Edwards Jesse E. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958; 18: 533-547. doi:10.1161/01.CIR.18.4.533
3. Wagenvoort C.A., Wagenvoort Noeke Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation. 1970; 42: 1163-1184.
4. Hatano S., Strasser T. eds. Primary pulmonary hypertension: Report on a WHO meeting. 1973, October 15-17; Geneva; Switzerland. WHO: Geneva; 1975. ISBN 92 4 156044 4 URL: https://apps.who.int/iris/bitstream/handle/10665/39094/9241560444_eng.pdf?sequence=1&isAllowed =y (дата обращения 1.03.2019).
5. Galiè Nazzareno, Rubin Lewis J. Introduction: new insights into a challenging disease: a review of the third world symposium on pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl): S1. doi:10.1016/j.jacc.2004.03.003
6. Humbert M., McLaughlin V.V. The 4th world Symposium on Pulmonary Hypertension. Introduction. J Am Coll Cardiol. 2009; 54 (1 Suppl): S1-2. doi:10.1016/j.jacc.2009.04.013
7. Galiè Nazzareno, Simonneau Gerald. The 5th World Symposium on Pulmonary Hypertension. J Am Coll Cardiol. 2013; 62 (25 Suppl D): D1-3. http://dx.doi.org/10.1016/j.jacc.2013.10.030
8. Galiè N., McLaughlin V.V., Rubin L.J., et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019; 53: 1802148. doi:10.1183/13993003.02148-2018
9. Barst R.J. Evaluation and treatment for angina in pulmonary arterial hypertension. Am J Med. 2004; 116 (6): 427-428. doi:10.1016/j.amjmed.2004.01.002
10. Badesch D.B., Champion H.C., Sanchez M.A., Hoeper M.M., Loyd J.E., Manes A., McGoon M., Naeije R., Olschewski H., Oudiz R.J., Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009; 54 (1 Suppl S): S55-66. doi:10.1016/j.jacc.2009.04.011
11. Simonneau G., Montani D., Celermajer D.S. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019; 53: 1801913. doi:10.1183/13993003.01913-2018
12. Humbert M., Guignabert C., Bonnet S. et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019; 53: 1801887. doi:10.1183/13993003.01887-2018
13. Pietra et al. Histopathology of Pulmonary Hypertension. JACC. 2004; 43 (12 Suppl S): 25S-32S. doi:10.1016/j.jacc.2004.02.033
14. Stewart S., Rassl D. Advances in the understanding and classification of pulmonary hypertension. Histopathology. 2009, 54: 104-116. doi:10.1111/j.1365-2559.2008.03180.x
15. Humbert M., Morrell N.W., Archer S.L., Stenmark K.R., MacLean M.R., Lang I.M., Christman B.W., Weir E.K., Eickelberg O., Voelkel N.F., Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004, 43 (12 Suppl S): 13S-24S. doi:10.1016/j.jacc.2004.02.029
16. Sitbon O., Gomberg-Maitland M., Granton J. et al. Clinical trial design and new therapies for pulmonary arterial hypertension. Eur Respir J. 2019; 53: 1801908. doi:10.1183/13993003.01908-2018
17. Newman J.H., Trembath R.C., Morse J.A., Grunig E. et al. Genetic basis of pulmonary hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 33S-39S. doi:10.1016/j.jacc.2004.02.028
18. Machado R.D., Eickelberg O., Elliott C.G., Geraci M.W. et al. JACC Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol. 2009; 54 (1 Suppl S): S32-42. doi:10.1016/j.jacc.2009.04.015
19. Soubrier F., Chung W.K., Machado R., Grünig E. et al. Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol. 2013; 62 (25 Suppl D): D13-21. doi:10.1016/j.jacc.2013.10.035
20. Morrell N.W., Aldred M.A., Chung W.K., Elliott C.G. et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019; 53: 1801899. doi:10.1183/13993003.01899-2018
21. Barst R.J., McGoon M., Torbicki A., Sitbon O., Krowka M.J., Olschewski H., Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl S): 40S-47S. doi:10.1016/j.jacc.2004.02.032
22. Badesch D.B., Champion H.C., Sanchez M.A., Hoeper M.M. et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009; 54 (1, Suppl S): S55-66. doi:10.1016/j.jacc.2009.04.011
23. Frost A., Badesch D., Gibbs J.S.R. et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019; 53: 1801904. doi:10.1183/13993003.01904-2018
24. Vachiéry J.-L., Tedford R.J., Rosenkranz S. et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019; 53: 1801897. doi:10.1183/13993003.01897-2018
25. Nathan S.D., Barbera J.A., Gaine S.P. et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019; 53: 1801914. doi:10.1183/13993003.01914-2018
26. Kim N.H., Delcroix M., Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019; 53: 1801915. doi:10.1183/13993003.01915-2018
27. Badesch D.B., McLaughlin V.V., Delcroix M., Vizza C.D., Olschewski H., Sitbon O., Barst R.J. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):56S–61S. doi:10.1016/j.jacc.2004.02.036
28. Channick R.N., Sitbon O., Barst R.J., Manes A., Rubin L.J. Endothelin receptor antagonists in pulmonary arterial hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 62S-67S. doi:10.1016/j.jacc.2004.02.042
29. Ghofrani H.A., Pepke-Zaba J., Barbera J.A., Channick R. et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 68S-72S. doi:10.1016/j.jacc.2004.02.031
30. Galiè N., Channick R.N., Frantz R.P., Grünig E. et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019; 53 1801889. doi:10.1183/13993003.01889-2018
31. Klepetko W., Mayer E., Sandoval J. et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl S): 73S-80S. doi:10.1016/j.jacc.2004.02.039
32. Keogh A.M., Mayer E., Benza R.L., Corris P. et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009; 54 (1, Suppl S): S67-77. doi:10.1016/j.jacc.2009.04.016
33. Hoeper M.M., Benza R.L., Corris P. et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019; 53: 1801906. doi:10.1183/13993003.01906-2018
34. Легочная гипертензия. Клинические рекомендации [ID: КР158] / Министерство здравоохранения Российской Федерации; Российское медицинское общество по артериальной гипертензии. 2016. URL: http://cr.rosminzdrav.ru/#!/recomend/136 (дата обращения 1.03.2019).
2. Heath Donald, Edwards Jesse E. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958; 18: 533-547. doi:10.1161/01.CIR.18.4.533
3. Wagenvoort C.A., Wagenvoort Noeke Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation. 1970; 42: 1163-1184.
4. Hatano S., Strasser T. eds. Primary pulmonary hypertension: Report on a WHO meeting. 1973, October 15-17; Geneva; Switzerland. WHO: Geneva; 1975. ISBN 92 4 156044 4 URL: https://apps.who.int/iris/bitstream/handle/10665/39094/9241560444_eng.pdf?sequence=1&isAllowed =y (дата обращения 1.03.2019).
5. Galiè Nazzareno, Rubin Lewis J. Introduction: new insights into a challenging disease: a review of the third world symposium on pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl): S1. doi:10.1016/j.jacc.2004.03.003
6. Humbert M., McLaughlin V.V. The 4th world Symposium on Pulmonary Hypertension. Introduction. J Am Coll Cardiol. 2009; 54 (1 Suppl): S1-2. doi:10.1016/j.jacc.2009.04.013
7. Galiè Nazzareno, Simonneau Gerald. The 5th World Symposium on Pulmonary Hypertension. J Am Coll Cardiol. 2013; 62 (25 Suppl D): D1-3. http://dx.doi.org/10.1016/j.jacc.2013.10.030
8. Galiè N., McLaughlin V.V., Rubin L.J., et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019; 53: 1802148. doi:10.1183/13993003.02148-2018
9. Barst R.J. Evaluation and treatment for angina in pulmonary arterial hypertension. Am J Med. 2004; 116 (6): 427-428. doi:10.1016/j.amjmed.2004.01.002
10. Badesch D.B., Champion H.C., Sanchez M.A., Hoeper M.M., Loyd J.E., Manes A., McGoon M., Naeije R., Olschewski H., Oudiz R.J., Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009; 54 (1 Suppl S): S55-66. doi:10.1016/j.jacc.2009.04.011
11. Simonneau G., Montani D., Celermajer D.S. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019; 53: 1801913. doi:10.1183/13993003.01913-2018
12. Humbert M., Guignabert C., Bonnet S. et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019; 53: 1801887. doi:10.1183/13993003.01887-2018
13. Pietra et al. Histopathology of Pulmonary Hypertension. JACC. 2004; 43 (12 Suppl S): 25S-32S. doi:10.1016/j.jacc.2004.02.033
14. Stewart S., Rassl D. Advances in the understanding and classification of pulmonary hypertension. Histopathology. 2009, 54: 104-116. doi:10.1111/j.1365-2559.2008.03180.x
15. Humbert M., Morrell N.W., Archer S.L., Stenmark K.R., MacLean M.R., Lang I.M., Christman B.W., Weir E.K., Eickelberg O., Voelkel N.F., Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004, 43 (12 Suppl S): 13S-24S. doi:10.1016/j.jacc.2004.02.029
16. Sitbon O., Gomberg-Maitland M., Granton J. et al. Clinical trial design and new therapies for pulmonary arterial hypertension. Eur Respir J. 2019; 53: 1801908. doi:10.1183/13993003.01908-2018
17. Newman J.H., Trembath R.C., Morse J.A., Grunig E. et al. Genetic basis of pulmonary hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 33S-39S. doi:10.1016/j.jacc.2004.02.028
18. Machado R.D., Eickelberg O., Elliott C.G., Geraci M.W. et al. JACC Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol. 2009; 54 (1 Suppl S): S32-42. doi:10.1016/j.jacc.2009.04.015
19. Soubrier F., Chung W.K., Machado R., Grünig E. et al. Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol. 2013; 62 (25 Suppl D): D13-21. doi:10.1016/j.jacc.2013.10.035
20. Morrell N.W., Aldred M.A., Chung W.K., Elliott C.G. et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019; 53: 1801899. doi:10.1183/13993003.01899-2018
21. Barst R.J., McGoon M., Torbicki A., Sitbon O., Krowka M.J., Olschewski H., Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl S): 40S-47S. doi:10.1016/j.jacc.2004.02.032
22. Badesch D.B., Champion H.C., Sanchez M.A., Hoeper M.M. et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009; 54 (1, Suppl S): S55-66. doi:10.1016/j.jacc.2009.04.011
23. Frost A., Badesch D., Gibbs J.S.R. et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019; 53: 1801904. doi:10.1183/13993003.01904-2018
24. Vachiéry J.-L., Tedford R.J., Rosenkranz S. et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019; 53: 1801897. doi:10.1183/13993003.01897-2018
25. Nathan S.D., Barbera J.A., Gaine S.P. et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019; 53: 1801914. doi:10.1183/13993003.01914-2018
26. Kim N.H., Delcroix M., Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019; 53: 1801915. doi:10.1183/13993003.01915-2018
27. Badesch D.B., McLaughlin V.V., Delcroix M., Vizza C.D., Olschewski H., Sitbon O., Barst R.J. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):56S–61S. doi:10.1016/j.jacc.2004.02.036
28. Channick R.N., Sitbon O., Barst R.J., Manes A., Rubin L.J. Endothelin receptor antagonists in pulmonary arterial hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 62S-67S. doi:10.1016/j.jacc.2004.02.042
29. Ghofrani H.A., Pepke-Zaba J., Barbera J.A., Channick R. et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension J Am Coll Cardiol. 2004; 43 (12 Suppl S): 68S-72S. doi:10.1016/j.jacc.2004.02.031
30. Galiè N., Channick R.N., Frantz R.P., Grünig E. et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019; 53 1801889. doi:10.1183/13993003.01889-2018
31. Klepetko W., Mayer E., Sandoval J. et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43 (12 Suppl S): 73S-80S. doi:10.1016/j.jacc.2004.02.039
32. Keogh A.M., Mayer E., Benza R.L., Corris P. et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009; 54 (1, Suppl S): S67-77. doi:10.1016/j.jacc.2009.04.016
33. Hoeper M.M., Benza R.L., Corris P. et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019; 53: 1801906. doi:10.1183/13993003.01906-2018
34. Легочная гипертензия. Клинические рекомендации [ID: КР158] / Министерство здравоохранения Российской Федерации; Российское медицинское общество по артериальной гипертензии. 2016. URL: http://cr.rosminzdrav.ru/#!/recomend/136 (дата обращения 1.03.2019).
Опубликована
2019-04-08
Как цитировать
ПОЛЯКОВ, К. В..
ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ: ОТ ABEL AYERZA ДО НАШИХ ДНЕЙ (ОБЗОР ЛИТЕРАТУРЫ).
Университетская клиника, [S.l.], n. 1(30), p. 87-93, апр. 2019.
ISSN 1819-0464. Доступно на: <http://journal.dnmu.ru/index.php/UC/article/view/298>. Дата доступа: 17 ноя. 2024
doi: https://doi.org/10.26435/uc.v0i1(30).298.
Раздел
Обзоры
